InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
36%
T+90 mean return
-3.2%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Dolsten Mikael, Director. Officer active across 4 companies, notably Agilent Technologies, INC.. In total, 24 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €196k. Activity tracked since 22 September 2021. The latest transaction was disclosed on 18 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations24 total
22,862 shares0Common StockSEC:0001140361-26-027679:0
1,600 shares@ US$135.420.0005% mcap15.3% of flowCommon StockSEC:0001090872-26-000057:0
14,312 sharesCommon StockSEC:0001193125-26-224624:0
14,312 sharesCommon StockSEC:0001193125-26-224624
14,220 shares0Common StockSEC:0001140361-25-015425:0
1,819 shares@ US$121.1816.6% of flowCommon StockSEC:0001127602-25-009721:0
1,678 shares@ US$147.4818.6% of flowCommon StockSEC:0001127602-24-010682:0
21,437 shares@ US$27.043.3% of flowCommon StockSEC:0001225208-24-003244:0
24,822 shares@ US$27.763.9% of flowCommon StockSEC:0001225208-24-003051:0
1,658 shares@ US$136.8217.6% of flowCommon StockSEC:0000899243-23-009221:0
37,078 shares@ US$41.758.9% of flowCommon StockSEC:0001225208-23-002917:0
32,592 shares@ US$42.387.9% of flowCommon StockSEC:0001225208-23-002811:0
50,938 shares@ US$30.179.5% of flowCommon StockSEC:0001225208-22-011483:0
200 shares@ US$49.360.0000% mcap0.1% of flowCommon StockSEC:0001225208-22-006909:0
1,785 shares@ US$136.820.0007% mcap57.0% of flowCommon StockSEC:0001127602-22-010048:0
62,022 shares@ US$27.340.0011% mcap14.1% of flowCommon StockSEC:0001225208-22-004229:0
29,744 shares@ US$47.720.0009% mcap11.7% of flowCommon StockSEC:0001225208-22-003662:0
29,767 shares@ US$46.870.0009% mcap11.3% of flowCommon StockSEC:0001225208-22-003473:0
71,187 shares@ US$30.1711.6% of flowCommon StockSEC:0001225208-21-015184
71,187 shares@ US$30.170.0013% mcap17.4% of flowCommon StockSEC:0001225208-21-015184:0
76,135 shares@ US$22.890.0011% mcap14.0% of flowCommon StockSEC:0001225208-21-013883:0
76,135 shares@ US$22.899.3% of flowCommon StockSEC:0001225208-21-013883
567 shares@ US$172.440.0003% mcap21.5% of flowCommon StockSEC:0001127602-21-025723:0
567 shares@ US$172.446.9% of flowCommon StockSEC:0001127602-21-025723
24 of 24 declarations
About Dolsten Mikael
Mikael Dolsten is a Director and President of R&D at Agilent Technologies, Inc., Pfizer Inc, and Apellis Pharmaceuticals, Inc. He plays a key role on the boards, bringing his expertise in research and development. His experience allows him to contribute to innovation and strategy for these companies.
